The Company develops, manufactures and commercializes innovative medical products that fight infection and inflammation.
| Current Price | $1.77 | Mkt Cap | $32.44M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 175.20 |
| Prev. Close | $1.75 | Div. (Yield) | 0.80 (45.20%) |
| Daily Range | $1.77 - $1.77 | Volume | 0 |
| 52-Wk Range | $0.25 - $1.79 | Avg. Daily Vol. | 0 |
| Subject | Recs | Author | Date |
|---|
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about NCST.
Recs
stevesliva
(95.45)
Submitted: 11/9/2006 6:52:40 PM :
Start Price:
$1.44
NCST Score:
+20.05
Oversold.
Recs
jwolfe5
(< 20)
Submitted: 11/8/2006 5:50:17 PM :
Start Price:
$1.43
NCST Score:
+20.91
NCST has bottomed out and is ready for several months of positive returns.
Recs
Braema
(< 20)
Submitted: 8/23/2006 5:50:18 PM :
Start Price:
$3.21
NCST Score:
-55.42
Small cap medical device company with a very good product.
Find the members with the highest scoring picks in NCST.
akalordx (97.01) Score: +70.48
The Score Leader is the player with the highest score across all their picks in NCST.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| akalordx | 97.01 | 7/23/2007 |
|
NS | $1.09 | +61.95% | -8.52% | +70.48 | 0 Comment | |
| mikeyuww | 34.03 | 10/26/2006 |
|
NS | $1.36 | +30.43% | +2.57% | +27.85 | 0 Comment | |
| jwolfe5 | < 20 | 11/9/2006 |
|
3M | $1.43 | +23.49% | +2.58% | +20.91 | 1 Comment | |
| stevesliva | 95.45 | 11/10/2006 |
|
5Y | $1.44 | +23.28% | +3.24% | +20.05 | 1 Comment | |
| TMFNosediveflip | 61.25 | 9/22/2006 |
|
1Y | $1.96 | -9.78% | +8.34% | +18.12 | 0 Comment | |
| bassin604 | 57.19 | 9/22/2006 |
|
3M | $1.94 | -8.79% | +8.13% | -16.91 | 0 Comment | |
| Braema | < 20 | 8/23/2006 |
|
1Y | $3.21 | -44.93% | +10.49% | -55.42 | 1 Comment | |
| SteadySaber | 76.00 | 7/23/2007 |
|
5Y | $1.08 | +64.33% | -8.39% | -72.72 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
